Laboratory Corporation of America Holdings

Company Profile

Laboratory Corporation of America Holdings had its IPO on 1990-03-29 under the ticker symbol LH.

The company operates in the Healthcare sector and Diagnostics & Research industry. Laboratory Corporation of America Holdings has a staff strength of 60,000 employees.

Stock update

Shares of Laboratory Corporation of America Holdings opened at $201.92 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $201.1 - $203.47, and closed at $201.59.

This is a -0.17% slip from the previous day's closing price.

A total volume of 807,160 shares were traded at the close of the day’s session.

In the last one week, shares of Laboratory Corporation of America Holdings have slipped by -2.42%.

Laboratory Corporation of America Holdings's Key Ratios

Laboratory Corporation of America Holdings has a market cap of $17.89 billion, indicating a price to book ratio of 2.0246 and a price to sales ratio of 1.3314.

In the last 12-months Laboratory Corporation of America Holdings’s revenue was $14.88 billion with a gross profit of $4.39 billion and an EBITDA of $2.23 billion. The EBITDA ratio measures Laboratory Corporation of America Holdings's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Laboratory Corporation of America Holdings’s operating margin was 11.29% while its return on assets stood at 5.51% with a return of equity of 9.94%.

In Q2, Laboratory Corporation of America Holdings’s quarterly earnings growth was a negative -45.2% while revenue growth was a positive 3.8%.

Laboratory Corporation of America Holdings’s PE and PEG Ratio

Forward PE

12.7877

Trailing PE

18.9428

PEG

2.0682

Its diluted EPS in the last 12-months stands at $10.66 per share while it has a forward price to earnings multiple of 12.7877 and a PEG multiple of 2.0682. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Laboratory Corporation of America Holdings’s profitability.

Laboratory Corporation of America Holdings stock is trading at a EV to sales ratio of 1.7232 and a EV to EBITDA ratio of 8.5819. Its price to sales ratio in the trailing 12-months stood at 1.3314.

Laboratory Corporation of America Holdings stock pays annual dividends of $2.88 per share, indicating a yield of 1.43% and a payout ratio of 17.52%.

Balance sheet and cash flow metrics

Total Assets

$17.71 billion

Total Liabilities

$2.18 billion

Operating Cash Flow

$-353300000.00

Capital Expenditure

$102.60 million

Dividend Payout Ratio

17.52%

Laboratory Corporation of America Holdings ended 2024 with $17.71 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $17.71 billion while shareholder equity stood at $8.77 billion.

Laboratory Corporation of America Holdings ended 2024 with $0 in deferred long-term liabilities, $2.18 billion in other current liabilities, 8100000.00 in common stock, $8.82 billion in retained earnings and $6.17 billion in goodwill. Its cash balance stood at $1.93 billion and cash and short-term investments were $1.93 billion. The company’s total short-term debt was $462,700,000 while long-term debt stood at $5.04 billion.

Laboratory Corporation of America Holdings’s total current assets stands at $5.12 billion while long-term investments were $67.20 million and short-term investments were $0. Its net receivables were $2.04 billion compared to accounts payable of $713.10 million and inventory worth $487.80 million.

In 2024, Laboratory Corporation of America Holdings's operating cash flow was $-353300000.00 while its capital expenditure stood at $102.60 million.

Comparatively, Laboratory Corporation of America Holdings paid $0.18 in dividends in 2024.

Other key metrics

Current Trading Price

$201.59

52-Week High

$221.5863

52-Week Low

$169.6936

Analyst Target Price

$250.49

Laboratory Corporation of America Holdings stock is currently trading at $201.59 per share. It touched a 52-week high of $221.5863 and a 52-week low of $221.5863. Analysts tracking the stock have a 12-month average target price of $250.49.

Its 50-day moving average was $212.34 and 200-day moving average was $201.98 The short ratio stood at 7.92 indicating a short percent outstanding of 0%.

Around 27.7% of the company’s stock are held by insiders while 9332.7% are held by institutions.